Biotechnology Sector

Recent advancements in solid-state ionics have brought to light the intricate mechanisms governing ion transport in lithium-ion conductors. The study conducted by Aydi, Dardouri, Znaidia, and their team delves deep into the realm of LISICON (Lithium Superionic Conductor) structures. By employing dielectric spectroscopy alongside electrothermal modeling, the researchers sought to unravel the complexities inherent in

A groundbreaking meta-analysis conducted by an international team of psychologists has unveiled a significant connection between environmental sensitivity and the prevalence of common mental health disorders, including depression and anxiety. This comprehensive synthesis of 33 studies, the first meta-analytic investigation of its kind, illuminates the nuanced ways in which highly sensitive individuals process external stimuli

In the evolving landscape of advanced manufacturing, the fusion of ceramics with additive manufacturing technologies has emerged as a frontier rich with potential. One recent study, conducted by Cramer et al., delivers significant advancement in the rheological optimization of silicon nitride and resin slurries engineered explicitly for vat photopolymerization printing followed by sintering. This development

Mount Sinai Marks 13th Year as Official Medical Provider at the US Open, Elevating Sports Medicine Through Advanced Onsite Care New York’s Mount Sinai Health System proudly continues its long-standing partnership as the official hospital and medical services provider for the US Open Tennis Championships, entering its 13th consecutive year in this prestigious role in

Over the last two decades, CD40 agonist antibodies have emerged as a beacon of hope in cancer immunotherapy, promising to marshal the immune system’s power against malignancies. Despite impressive results in preclinical animal models, their translation to human therapy has been fraught with challenges. Systemic toxicity, including severe inflammatory responses, thrombocytopenia, and hepatotoxicity, severely limited

America’s mental health crisis among youth has escalated to alarming levels, with new research revealing a troubling pattern of extended stays for children in hospital emergency departments. According to the latest study conducted by Oregon Health & Science University (OHSU), a significant number of young patients suffering primarily from suicide-related behaviors and depression are forced

The pharmaceutical industry is undergoing a profound transformation as artificial intelligence, particularly large language models (LLMs), begins to redefine the very fabric of drug development. These advanced AI architectures, which underpin next-generation chatbots, are proving to be more than just computational tools; they are becoming pivotal collaborators in accelerating and enhancing drug discovery and development.

In recent years, the landscape of cancer therapy has witnessed a transformative shift towards precision oncology, with an emerging frontier rooted in the electrophysiological properties of tumors. Tumor cells exhibit distinctive bioelectrical characteristics that not only underpin malignant behaviors but also offer novel, targetable vulnerabilities for therapeutic intervention. At the core of these abnormalities lies

A groundbreaking study has emerged from leading researchers at Fudan University Shanghai Cancer Center and the Shanghai Institute for Biomedical and Pharmaceutical Technologies, illuminating a transformative pathway in the treatment of triple-negative breast cancer (TNBC). This aggressive breast cancer subtype, characterized by the absence of estrogen receptor, progesterone receptor, and HER2 expression, has long defied

In the realm of retinal diseases, macular edema (ME) stands as a formidable adversary to central vision, frequently undermining the clarity and sharpness that define human sight. Characterized by the abnormal accumulation of fluid within the macula—the retina’s central zone responsible for high-resolution vision—ME arises primarily due to retinal vascular leakage in disorders such as

Substance use recovery is an arduous and lifelong journey that challenges individuals at every turn, especially when confronted with environmental stimuli capable of triggering relapse. These triggers—commonly encountered in everyday settings like social gatherings where alcohol is present or via advertisements for prescription pain medications—pose significant risks for those navigating sobriety. Recently, a pioneering study

In recent years, the intricate relationship between the human gut microbiota and cardiovascular health has emerged as a groundbreaking area of biomedical research, radically reshaping our understanding of heart failure pathogenesis. Heart failure, a complex clinical syndrome characterized by impaired cardiac function and high morbidity, is now increasingly recognized to be influenced by the dynamic

ADAMTS2: Unlocking the Multifaceted Roles of a Crucial Metalloproteinase Beyond Collagen Processing ADAMTS2, a pivotal member of the ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin motifs) zinc metalloproteinase family, has long been recognized for its specialized enzymatic function as a procollagen I N-proteinase. This activity is essential for the post-translational maturation of fibrillar collagens, which

Fasting has surged to the forefront of popular health trends, embraced by millions seeking weight loss and metabolic benefits. Yet, emerging research from the University of British Columbia Okanagan (UBCO) reveals that the metabolic and immunological responses to fasting are far from uniform across different body types. In particular, individuals living with obesity demonstrate a

Fucosylation stands as a pivotal post-translational modification intricately woven into the molecular fabric of cellular biology. This biochemical process facilitates the transfer of fucose, a hexose sugar, onto glycoproteins and glycolipids, thereby modulating a spectrum of physiological phenomena. Recent research in molecular medicine has cast fucosylation into the limelight, revealing its profound influence on the

Platelets: Beyond Clotting—Unveiling Their Role in DNA Surveillance and Cancer Detection August 15, 2025, New York – Platelets, well-recognized for their crucial role in hemostasis and wound healing, are revealing new dimensions in human biology that extend far beyond simple blood clot formation. Traditionally seen as tiny cellular fragments that facilitate scab formation and can

In the current landscape of energy storage technology, the demand for efficient, long-lasting, and sustainable solutions is ever-increasing. A recent publication in the journal Ionics has put forth a groundbreaking study by Zhao, Luo, and Huang, outlining a simplified design and synthesis method for one-dimensional titanate nanotubes. These novel structures are poised to become advanced

Acute kidney injury (AKI) persists as a formidable clinical challenge worldwide, exacting a heavy toll in terms of morbidity, mortality, and long-term healthcare costs. Despite advances in critical care and nephrology, effective therapeutic strategies that can halt or reverse the progression of AKI remain scarce. Mounting evidence now spotlights mitochondrial biogenesis—the process by which cells

A groundbreaking review article recently published in Genes & Diseases offers an intricate and expansive analysis of tumor angiogenesis, particularly emphasizing the enigmatic origins and multifaceted nature of endothelial cells (ECs) within the tumor microenvironment. Tumor angiogenesis, the process of new blood vessel formation, is fundamental to cancer progression, as it facilitates the unrestrained growth

CAMBRIDGE, MA — Graphite, a seemingly simple form of carbon, stands as a pillar of nuclear reactor technology, integral both to the world’s earliest nuclear reactors and the advanced systems being designed today. Its role as a neutron moderator is critical: graphite slows the high-energy neutrons released during fission reactions, increasing the likelihood of sustained

About a week ago, on August 8th, fell International Cat Day. Even if you are a cat person like I am, you might have missed the event. Don’t worry, your feline probably didn’t know about it either. In this article, we will take a look at what biotech is doing in cat health. While the cat The post How biotech is improving the life of your cat  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

This week's guest is Cosmo Feilding of Beckley PsyTech, a UK biotech working with next generation psychedelics that could redefine depression treatment. The post Are next-generation psychedelics the way forward for addressing treatment resistant depression? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Omeros’ efforts to get its transplant drug to market have already suffered one FDA rejection. Now, the biotech’s second shot at approval has been pushed back by three months.

Experienced business developer Derek Hicks has been handed the reins of Rezo Therapeutics, his first time at the helm of a biotech. Hicks most recently was chief business officer at Intellia Therapeutics and before that served a yearlong stint as head of business development at Spark Therapeutics.

Evotec previously planned to lay off 400 staffers amid a sweeping reorganization. It has actually cut roughly 600 as of June.

Prelude Therapeutics’ lead asset won’t be making it to the second act. The precision oncology outfit is pausing development of SMARCA2 degrader PRT3789, leaving just one clinical program left humming in its pipeline.

Having backed Superluminal Medicines’ series A last year, Eli Lilly has now signed a $1.3 billion pact with the G protein-coupled receptor biotech.

Schrödinger is abandoning its CDC7 inhibitor after the therapy was linked to the deaths of two patients in a phase 1 leukemia trial.

A patient has died from kidney injury in a trial of CytomX Therapeutics’ lead antibody-drug conjugate, although the biotech has been advised to stick with the study.

Sarepta Therapeutics is selling off Arrowhead Pharmaceuticals shares to stretch its cash runway while also inking a share transfer to pay off half of a $100 million payment owed to the latter.

Vedanta Biosciences’ dreams of using live bacteria to treat inflammatory bowel disease have been dashed. The Massachusetts-based microbiome outfit’s mixture of 16 bacterial strains failed to reduce disease severity in the colons of patients with ulcerative colitis, Vedanta said Wednesday.

Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly skin cancer. The post Injecting hope into skin cancer treatment: The promise of melanoma vaccines appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Hatteras Venture Partners has secured over $200 million across a pair of funds that are set to benefit up-and-coming biotechs alongside medtech and healthtech companies.

Response Pharmaceuticals has shared phase 2 data in post-GLP-1 patients, linking its ex-Sanofi asset to reductions in blood-fat levels and weight gain in previous users of obesity drugs.

Oric’s previously announced plan to focus resources come with a sting in its tail—the therapeutic resistance-focused biotech is laying off 20% of its employees to finance the strategy.

Generation Bio is shedding 90% of its workforce after the biotech acknowledged that it’s unlikely to find the cash to take its lipid nanoparticle tech into the clinic.

More bad news has come down for Biohaven’s small molecule troriluzole. After the FDA decided to convene an advisory committee to consider the asset’s potential approval in a rare disease, pushing the PDUFA date to the fourth quarter, troriluzole has now failed a phase 3 trial in obsessive-compulsive disorder.

The director of the National Institutes of Health has attributed the federal government’s discontinuation of mRNA vaccine development to a lack of public trust that has made the platform “no longer viable."

Discover six of the top psychedelic companies developing novel drugs to expand the treatment scope for mental health indications. The post Six psychedelic drug companies aiming to revolutionize mental health treatment appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

After HHS abruptly canceled about $500 million in funding for mRNA vaccine development, one senior agency leader has decided to call it quits. Alastair Thomson is resigning as chief data officer at the Advanced Research Projects Agency for Health, he announced in a LinkedIn post that has since been deleted.

Using its hub-and-spoke business model, PureTech is launching a new subsidiary, Celea Therapeutics, to develop its promising candidate for idiopathic pulmonary fibrosis (IPF) and other fibrotic and inflammatory lung conditions.

Bayer has teamed up with Kumquat Biosciences for a juicy opportunity, committing up to $1.3 billion for the global license to a KRAS G12D inhibitor that is on the cusp of the clinic.

A day after posting a pair of phase 3 wins for the tricky indication of Sjögren's syndrome, the Swiss pharma has unveiled a separate late-stage victory in another B-cell-driven autoimmune disease.

Vaxart is actively seeking more information about why it was told to stop work under a federally funded COVID-19 vaccine contract.

Another Massachusetts biotech has reached the end of the road. NextRNA Therapeutics has begun winding down operations with a “heavy heart,” the company’s co-founder, president and CEO Dominique Verhelle, Ph.D., announced in an Aug. 9 LinkedIn post.

Zombie biotechs continue to exist despite setbacks. Some players in the industry want to free the capital and eliminate these companies. The post Zombie biotechs and the mission to make them disappear fast appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Young inflammatory disease biotech Expedition Therapeutics is paying $17 million cash for licensing rights to an investigational DPP-1 inhibitor from Fosun Pharma.

IO Biotech’s cancer vaccine has “narrowly” failed to beat Keytruda in a phase 3 melanoma trial, but the company remains hopeful of a path to approval.

Novartis may have abandoned one of its Sjögren's syndrome assets this year, but it now looks like the pharma has a winner on its hands.

Learn about July 2025’s top biotech deals, featuring major collaborations in small molecules, antibodies, and drug delivery. The post Top biotech deals in July 2025  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Recently the UK government announced plans to sequence the DNA of every baby born in that country. Why, how, and what will it cost? The post Day One DNA: How and why the UK is betting on whole genome sequencing for every newborn appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Fusion proteins have drawn investors these past months attracting dollars from deep pockets in the pursuit of commercial success.  The post Fusion proteins attract funds and biopharma partnerships  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Discover 10 key oncology deals that have been made so far in 2025, spotlighting where industry leaders are betting big. The post 10 oncology deals in 2025 spotlight where industry leaders are betting big appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall in July 2025. The post The biggest biotech funding rounds in July 2025 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

This past year has seen various developments in the field of oncolytic virus therapies - in fundraising and in the clinic. The post Oncolytic virus therapy for cancer: what’s been going on in 2025?  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Is cultivated meat the future of pet food? Meatly's CEO shares how lab-grown meat is changing pet diets—and possibly human ones too. The post Meatly’s innovative cultivated meat is already delighting pets, are humans next? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Navigating the Complex World of Global Drug Patents: Strategies and Challenges Ahead As a pharmaceutical professional, you know how crucial it is to protect your innovative drug patents in the global market. With the rise of international trade and the... Source

The Complex World of Biologic Drugs: Navigating Patent Applications As a biotech professional, you're likely no stranger to the intricacies of developing life-saving treatments. But when it comes to biologic drugs, the process can be particularly chall... Source

Unlocking the Power of Combination Therapies: Strategies for Successful Patenting As a pharmaceutical professional, you know that combination therapies have revolutionized the treatment of complex diseases. By pairing two or more active ingredients, yo... Source

The Secret to Setting the Right Price for Your Generic Medications As a generic drug manufacturer, you're constantly looking for ways to stay ahead of the competition and bring affordable medications to market. But have you ever wondered how to set the... Source

Unlocking Efficiency in the Generic Drug Supply Chain As the pharmaceutical industry continues to evolve, the generic drug supply chain has become a critical component of ensuring timely and affordable access to life-saving medications. However, naviga... Source

Breaking News: FDA Updates - What Do the Latest Changes Mean for Generic Drug Approval? As a healthcare professional or a business leader in the pharmaceutical industry, you're likely aware of the complex landscape surrounding generic drug approval. Re... Source

Breaking Down Barriers: Navigating Regulatory Challenges in Latin America's Generic Drug Market As the demand for affordable generic medications continues to grow, Latin America has emerged as a critical region for pharmaceutical companies looking to e... Source

The Future of Affordable Healthcare: Can Biosimilars Deliver? As healthcare professionals, we're constantly on the lookout for innovative solutions to improve patient outcomes while reducing costs. One promising approach is the use of biosimilars – bio... Source

Ensuring the Highest Quality in Generic Medications: A Crucial Step in Healthcare As the global demand for affordable healthcare continues to rise, generic medications have become a vital lifeline for millions of people worldwide. However, with the inc... Source

The Unseen Heroes of Generic Medicines: The Crucial Role of Quality Assurance As we navigate the complex world of pharmaceuticals, it's easy to overlook the unsung heroes behind the scenes. But today, I want to shine a spotlight on the Quality Assuranc... Source

Can Lurbinectedin Treat Ovarian Cancer? A Comprehensive Review Ovarian cancer is a devastating disease that affects thousands... https://www.Drugchatter.com/chat/25460/can-lurbinectedin-treat-ovarian-cancer/ Source

Unlocking the Potential of Biosimilars: Navigating Regulatory Considerations for Clinical Efficacy Trials As the pharmaceutical industry continues to evolve, biosimilars have emerged as a game-changer in the quest for affordable and accessible treatmen... Source

Unlock the Secrets of Drug Patent Searching: A Beginner's Guide As a professional in the pharmaceutical industry, staying ahead of the curve is crucial. One of the most critical aspects of this is understanding the world of drug patents. But have you e... Source

Unlocking the Path to Generic Medication Approval: A Step-by-Step Guide As a healthcare professional or a business leader in the pharmaceutical industry, you're likely aware of the complex landscape surrounding generic medication approval. With the eve... Source

The Future of Biosimilars: Switching Strategies for Success As the biosimilar market continues to grow, one question on everyone's mind is: how can we make the most of this opportunity? One strategy that's gaining traction is biosimilar-to-biosimilar s... Source

The Hidden Factors Behind FDA-Approved Drugs' Patent Challenges As a healthcare professional or a pharmaceutical industry expert, you're likely no stranger to the complex world of drug patents. But have you ever wondered what sets some FDA-approved dru... Source

Breaking Down Barriers: The Power of Partnerships in Generic Drug Development As the pharmaceutical industry continues to evolve, one thing is clear: collaboration is key. In the world of generic drug development, partnerships are playing an increasing... Source

Does Fish Oil Interact with Vascepa? A Comprehensive Guide As the world becomes increasingly aware of the importance of... https://www.Drugchatter.com/chat/45752/does-fish-oil-interact-with-vascepa/ Source

The Art of Timing: Mastering Generic Drug Development Timelines As a seasoned professional in the pharmaceutical industry, you know that navigating the complex landscape of generic drug development can be a daunting task. One of the most critical facto... Source

The Impact of Lipitor on White Wine: A Comprehensive Guide As a popular cholesterol-lowering medication, Lipitor (atorvastatin)... https://www.Drugchatter.com/chat/37341/how-does-lipitor-affect-white-wine/ Source

As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.